Actual Management of Patients with Familial Ascending Aortic Aneurysms and Type-A Aortic Dissections

Abstract

Background: There are few families with the diagnosis of ascending aortic aneurysm and acute type-A aortic dissection inherited as an autosomal-dominant disorder in the absence of a known genetic syndrome. Methods: We investigated a family with 26 members in whom ascending aortic aneurysms and acute type-A aortic dissections occurred over three generations. Examinations were performed to identify family members at specific risk. Results: Six members presented with acute type-A aortic dissections and three relatives had ascending aortic aneurysms. Clinical examinations showed no characteristics of a known genetic syndrome. Molecular genetic analysis revealed no mutations known to cause a form of autosomal-dominant inherited aortic disease. Conclusion: Adequate diagnostic measures are mandatory in families with ascending aortic aneurysms or type-A aortic dissections to identify or exclude family members at risk for aortic diseases. Even in the absence of identifiable mutations causing isolated aortic aneurysms or aortic dissections, we recommend standardised examinations of all first-degree relatives of affected families. An indication for prophylactic aortic root replacement should be considered for patients at risk.

Key words

aortic disease - familial type‐A aortic dissection - familial ascending aortic aneurysm - unknown genetic syndrome

References

• 1 Marfan A B. Un cas de déformation congénitale des quatre membres plus prononcée aux extrémités charactérisée par l'allongement des os avec un certain degré d'amincisement.  Bull Mem Soc Med Hospital (Paris). 1896;  13 220-226
• 2 Milewicz D M, Dietz H C, Miller D C. Treatment of aortic disease in patients with Marfan syndrome.  Circul. 2005;  111 150-157
• 3 Kodolitsch v. Y, Raghunath M, Nienaber CA: Das Marfan-Syndrom: Prävalenz und natürlicher Verlauf der kardiovaskulären Manifestationen.  Z Kardiol. 1998;  87 150-160
• 4 Dietz H C, Cutting C R, Pyeritz R E. et al . Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene.  Nature. 1991;  352 337-339
• 5 Kainulainen K, Pulkkinen L, Savolainen A, Kaitila I, Peltonen L. Location on chromosome 15 of the gene causing Marfan syndrome.  N Engl J Med. 1990;  323 935-939
• 6 Murdoch J L, Walker B A, Halpern B L, Kuzma J W, McKusick V A. Life expectancy and causes of death in the Marfan syndrome.  N Engl J Med. 1972;  286 804-808
• 7 Pyeritz R E. The Marfan syndrome.  Annu Rev Med. 2000;  51 481-510
• 8 Robinson P N, Godfrey M. The molecular genetics of Marfan syndrome and related microfibrillopathies.  J Med Genet. 2000;  37 9-25
• 9 Apostolopoulos T D, Kyriakidis M K, Kitsiou S A, Galla-Voumvouraki A D, Tsezou A N, Toutouzas P K. Turner syndrome with normal ovarial function and multiple malformations of the aorta.  Postgrad Med J. 1994;  70 838-840
• 10 Kretschmar K, Witkowski R. Dissecting aortic aneurysm in a man with symptoms of Turner's syndrome.  Z Gesamte Inn Med. 1982;  37 278-281
• 11 Lin A E, Garver K L, Allanson J. Aortic root dilatation in Noonan's syndrome.  N Engl J Med. 1987;  317 1668-1669
• 12 Purnell R, Williams I, von Oppell U, Wood A. Giant aneurysms of the sinuses of Valsalva and aortic regurgitation in a patient with Noonan's syndrome.  Eur J Cardiothorac Surg. 2005;  28 346-348
• 13 Morgan J M, Coupe M O, Honey M, Miller G A. Aneurysms of the sinuses of Valsalva in Noonan's syndrome.  Eur Heart J. 1989;  10 190-193
• 14 Shachter N, Perloff J K, Mulder D G. Aortic dissection in Noonan's syndrome (46 XY turner).  Am J Cardiol. 1984;  54 464-465
• 15 Hamano K, Minami Y, Fujimura Y. et al . Emergency operation for thoracic aortic aneurysm caused by the Ehlers-Danlos syndrome.  Ann Thorac Surg. 1994;  58 1180-1182
• 16 Bixler D, Antley R M. Familial aortic dissection with iris anomalies - a new connective tissue disease syndrome?.  Birth Defects Orig Artic Ser. 1976;  12 229-234
• 17 McManus B M, Cassling R S, Soundy T J, Wilson J E, Sears T D. Familial aortic dissection in absence of ascending aortic aneurysms: a lethal syndrome associated with precocious systemic hypertension.  Am J Cardiovasc Pathol. 1986;  1 55-67
• 18 Nicod P, Bloor C, Godfrey M. et al . Familial aortic dissecting aneurysm.  J Am Coll Cardiol. 1989;  13 811-819
• 19 Toyama M, Amano A, Kameda T. Familial aortic dissection: a report of rare family cluster.  Br Heart J. 1989;  61 204-207
• 20 Warnes C A, Kirkmann P M, Roberts W C. Aortic dissection in more than one family member.  Am J Cardiol. 1985;  55 236-238
• 21 Teien D, Finley J P, Murphy D A, Lacson A, Longhi J, Gillis D A. Idiopathic dilatation of the aorta with dissection in a family without Marfan syndrome.  Acta Paediatr Scand. 1991;  80 1246-1249
• 22 Hasham S N, Willing M C, Guo D C. et al . Mapping a locus for familial thoracic aortic aneurysms and dissections (TAAD2) to 3p24-25.  Circul. 2003;  107 3184-3190
• 23 Guo D, Hasham S, Kuang S Q. et al . Familial thoracic aortic aneurysm and dissections.  Circul. 2001;  103 2461-2468
• 24 Vaughan C J, Casey M, He J. et al . Identification of a chromosome 11q23.2-q24 locus for familial aortic aneurysm disease, a genetically heterogeneous disorder.  Circul. 2001;  103 2469-2475
• 25 Tiecke F, Katzke S, Booms P. et al . Classic, atypically severe and neonatal Marfan syndrome: twelve mutations and genotype-phenotype correlations in FBN1 exons 24 - 40.  Eur J Hum Genet. 2001;  9 13-21
• 26 De Paepe A, Devereux R B, Dietz H C, Hennekam R C, Pyeritz R E. Revised diagnostic criteria for the Marfan syndrome.  Am J Med Genet. 1996;  62 417-426
• 27 Francke U, Berg M A, Tynan K. et al . A Gly1127Ser mutation in an EGF-like domain of the fibrillin-1 gene is a risk factor for ascending aortic aneurysm and dissection.  Am J Hum Genet. 1995;  56 1287-1296
• 28 Whiteman P, Handford P A. Defective secretion of recombinant fragments of fibrillin-1: implications of protein misfolding for the pathogenesis of Marfan syndrome and related disorders.  Hum Molec Genet. 2003;  7 727-737
• 29 Whiteman P, Smallridge R S, Knott V, Cordle J J, Downing A K, Handford P A. A G1127S change in calcium-binding epidermal growth factor-like domain 13 of human fibrillin-1 causes short range conformational effects.  J Biol Chem. 2001;  276 17156-17162
• 30 Shores J, Berger K R, Murphy E A, Pyeritz R E. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome.  N Engl J Med. 1994;  330 1335-1341